ALINT Share Price

Open 3.41 Change Price %
High 3.69 1 Day 0.22 6.45
Low 3.20 1 Week 0.66 22.22
Close 3.63 1 Month 0.68 23.05
Volume 124284 1 Year -2.07 -36.32
52 Week High 5.86
52 Week Low 2.51
ALINT Important Levels
Resistance 2 4.08
Resistance 1 3.90
Pivot 3.51
Support 1 3.36
Support 2 3.18
EPA France Most Active Stocks
MT 4.53 12.97%
MT 4.53 12.97%
MT 4.53 12.97%
MT 4.53 12.97%
MT 4.53 12.97%
SOI 1.38 11.29%
SOI 1.38 11.29%
SOI 1.38 11.29%
GSZ 17.56 3.97%
GSZ 17.56 3.97%
More..
EPA France Top Gainers Stocks
ALALO 0.04 33.33%
APAM 33.78 15.72%
APAM 33.78 15.72%
ALSAS 6.29 15.62%
MLLOI 3.80 15.15%
AVQ 0.16 14.29%
DEXB 17.47 13.89%
DEXB 17.47 13.89%
MT 4.53 12.97%
MT 4.53 12.97%
More..
EPA France Top Losers Stocks
MLCAC 8.00 -21.95%
MLDEX 0.30 -18.92%
AVT 0.05 -16.67%
AVT 0.05 -16.67%
AVT 0.05 -16.67%
AVT 0.05 -16.67%
VRNL 0.51 -12.07%
EBPF 85.50 -10.00%
ALMAS 0.79 -9.20%
TONN 1.01 -8.18%
More..

Integragen (EPA: ALINT)

ALINT Technical Analysis 5
As on 9th Dec 2016 ALINT Share Price closed @ 3.63 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 3.17 & Strong Buy for SHORT-TERM with Stoploss of 3.11 we also expect STOCK to react on Following IMPORTANT LEVELS.
ALINT Target for December
1st Target up-side 3.04
2nd Target up-side 3.17
3rd Target up-side 3.29
1st Target down-side 2.68
2nd Target down-side 2.55
3rd Target down-side 2.43
ALINT Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Biotechnology
Offical website http://www.integragen.fr
ALINT Address
ALINT
Genopole Campus 1 - Genavenir 8
5 rue Henri Desbru
Evry, 91000
France
Phone: 33 1 60 91 09 00
Fax: 33 1 60 77 79 10
ALINT Latest News
Genetic Testing Market Analysis, Size, Trends, Share, Report and Forecast to 2022   NewsMaker (press release)   - 05th Dec 16
Ovarian Cancer Diagnostic Tests Market 2016 Pipeline Assessment   PR Newswire (press release)   - 03rd Oct 16
Global Genetic Testing Market 2016-2022 - Insights, Opportunity Analysis ...   Business Wire (press release)   - 08th Jun 16
New England Biolabs® Launches NEBNext Direct™ Technology with Cancer HotSpot ...   PR Newswire (press release)   - 14th Apr 16
Global Genetic Testing Market Outlook (2015-2022)   PR Newswire (press release)   - 12th Aug 15
IntegraGen Announces Distribution Agreement for Autism Risk Assessment Test   Business Wire (press release)   - 05th Feb 15
Next Generation Cancer Diagnostics: Technologies and Global Markets   PR Newswire (press release)   - 04th Sep 14
World Market for Molecular Diagnostics, 5th. Edition (Infectious Disease ...   PR Newswire (press release)   - 11th Feb 13
Researchers identify 57 SNPs associated with autism   News-Medical.net   - 18th May 12
IntegraGen Launches ARISk™ Test, a Genetic Screening Tool for Autism in High ...   Business Wire (press release)   - 04th Apr 12
Interactive Technical Analysis Chart Integragen ( ALINT EPA France )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Integragen
ALINT Business Profile
IntegraGen S.A. develops molecular diagnosis tests to identify treatments for pathologies in France. The company develops biomarkers for use as diagnostic tools in the fields of autism, oncology, diabetes, and obesity. It offers DNA extraction, sample management, and storage services; NextGen sequencing services; SNP genotyping services; and methylation analysis, which include DNA sample reception and QC, bisulfite conversion, genotyping analysis, data quality control, delivery of methylation value, and delivery of genome studio project file for data analysis with genome studio software. The company was founded in 2001 and is headquartered in Evry, France.